93591-87-8

Basic information

• Product Name: 1-Methyl-N-(4-nitrophenyl)piperidin-4-amine
• Synonyms: 1-Methyl-N-(4-nitrophenyl)piperidin-4-amine;(1-Methyl-piperidin-4-yl)-(4-nitro-phenyl)-amine
• CAS NO: 93591-87-8
• Molecular Formula: C₁₂H₁₇N₃O₂
• Molecular Weight: 235.28228
• Mol File: 93591-87-8.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-Methyl-N-(4-nitrophenyl)piperidin-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Methyl-N-(4-nitrophenyl)piperidin-4-amine(93591-87-8)
• EPA Substance Registry System: 1-Methyl-N-(4-nitrophenyl)piperidin-4-amine(93591-87-8)

Safety Data

• Hazardous Substances Data: 93591-87-8(Hazardous Substances Data)

Usage

Piperidine derivative

A derivative of piperidine This indicates that the compound is based on the piperidine ring structure, which is a six-membered heterocyclic ring containing one nitrogen atom.

4-Nitrophenyl substituent

A nitro group (-NO2) attached to a phenyl ring (a carbon ring structure) This functional group is attached to the amine nitrogen, influencing the compound's reactivity and potential applications.

Potential applications in medicinal chemistry

Use in the development of pharmaceuticals This suggests that the compound may be useful in creating new drugs, particularly those targeting neuroreceptors or as a precursor for other biologically active compounds.

Unique pharmacological properties

Possessing distinct characteristics that make it of interest for further research This highlights the potential for the compound to have properties that are different from other similar compounds, making it a valuable subject for further study and development in the pharmaceutical industry.

Upstream product

• 41838-46-4 4-Amino-1-methylpiperidine 
• 350-46-9 4-Fluoronitrobenzene 

Downstream Products

• 99918-29-3 (2-Chloro-phenyl)-[2-(1-methyl-piperidin-4-ylamino)-5-nitro-phenyl]-methanone 
• 1086392-72-4 N-(1-methylpiperidin-4-yl)benzene-1,4-diamine 

Relevant articles and documents

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.

1,4-Benzodiazepine derivatives

1,4-Benzodiazepine derivatives of the formula: STR1 (in which R1 is pyrrolidinyl or piperidinyl each optionally substituted by C1-3 alkyl, phenyl-C1-3 alkyl, C1-5 alkanoyl, or C2-5 alkoxycarbonyl, R2 is hydrogen, hydroxy, or acetoxy, R3 is C1-3 alkyl, phenyl-C1-3 alkyl, or phenyl optionally substituted by one or two halogens, X is hydrogen, halogen, C1-3 alkyl, C1-3 alkoxy, nitro, trifluoromethyl, or di-C1-3 alkyl-amino, and n is 1 or 2) or pharmaceutically acceptable acid addition salts thereof, which are useful as a psychotropic agent such as anti-depressant or anxiolytic agent can be prepared from several routes.